20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Eton Pharmaceuticals Inc (ETON) operates in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry and is headquartered in Deer Park, United States with about 44 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, ETON reported $80M in revenue and ($5M) in net income.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
Interactive charts & full statements → Open the ETON valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $105M | $80M | $39M | $32M | $21M | $22M | $0M | $1M | $0M | $0M |
| Gross Profit | $61M | $43M | $23M | $21M | $14M | $19M | $0M | $1M | $0M | $0M |
| Gross Margin % | 58.1% | 53.5% | 60.0% | 66.6% | 67.4% | 88.0% | -633.3% | 52.8% | — | — |
| Operating Income (EBIT) | $16M | $0M | ($3M) | ($1M) | ($8M) | ($1M) | ($27M) | ($19M) | ($10M) | ($7M) |
| Operating Margin % | 15.2% | 0.1% | -6.7% | -3.8% | -38.9% | -6.9% | -69515.4% | -1939.6% | — | — |
| Net Income | $13M | ($5M) | ($4M) | ($1M) | ($9M) | ($2M) | ($28M) | ($18M) | ($13M) | ($7M) |
| Net Margin % | 12.4% | -5.8% | -9.8% | -3.0% | -42.4% | -8.9% | -71717.9% | -1910.3% | — | — |
| EBITDA | $19M | $4M | ($1M) | $0M | ($7M) | ($1M) | ($26M) | ($18M) | ($10M) | ($7M) |
| Earnings Per Share (EPS) | $0.37 | $-0.17 | $-0.15 | $-0.04 | $-0.36 | $-0.08 | $-1.33 | $-1.03 | $-1.99 | $-0.41 |
| Shares Outstanding (M) | 33M | 27M | 26M | 26M | 25M | 25M | 21M | 18M | 6M | 17M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $38M | $24M | $21M | $22M | $19M | $17M | $12M | $10M |
| Gross Profit | $25M | $15M | $13M | $8M | $12M | $10M | $6M | $6M |
| Gross Margin % | 67.6% | 60.7% | 61.6% | 35.0% | 63.0% | 57.1% | 55.6% | 61.0% |
| Operating Income (EBIT) | $13M | $2M | $2M | ($1M) | ($1M) | $0M | $1M | $1M |
| Operating Margin % | 34.0% | 10.0% | 11.6% | -6.1% | -7.8% | -2.7% | 5.4% | 4.9% |
| Net Income | $12M | $2M | $1M | ($2M) | ($3M) | ($2M) | ($1M) | $1M |
| Net Margin % | 30.8% | 6.4% | 7.0% | -8.6% | -13.7% | -9.1% | -5.1% | 6.1% |
| EBITDA | $13M | $2M | $4M | $0M | $0M | $1M | $0M | $1M |
| Earnings Per Share (EPS) | $0.35 | $0.05 | $0.04 | $-0.07 | $-0.10 | $-0.06 | $-0.02 | $0.02 |
| Shares Outstanding (M) | 33M | 32M | 27M | 27M | 27M | 27M | 26M | 27M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $14M | $11M | $1M | $7M | $5M | ($5M) | ($22M) | ($18M) | ($8M) | ($5M) |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $1M | $3M | $3M | $0M | $2M | $0M | $0M |
| Free Cash Flow (FCF) | $14M | $10M | $1M | $6M | $2M | ($8M) | ($22M) | ($20M) | ($8M) | ($5M) |
| FCF Margin % | 13.3% | 12.8% | 2.4% | 19.1% | 9.6% | -36.5% | -57425.6% | -2072.2% | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | $1M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $7M | $7M | ($12M) | $12M | $8M | $2M | ($1M) | $3M |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $2M |
| Free Cash Flow (FCF) | $7M | $7M | ($12M) | $12M | $8M | $2M | ($1M) | $1M |
| FCF Margin % | 19.3% | 30.2% | -54.5% | 52.3% | 42.0% | 12.1% | -6.7% | 10.5% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $116M | $92M | $76M | $32M | $25M | $27M | $26M | $17M | $28M | $13M |
| Cash & Cash Equivalents | $27M | $26M | $15M | $21M | $16M | $14M | $21M | $12M | $27M | $13M |
| Total Liabilities | $69M | $66M | $52M | $16M | $12M | $10M | $11M | $7M | $2M | $1M |
| Total Debt (Short + Long-Term) | $28M | $31M | $30M | $5M | $6M | $7M | $7M | $5M | $0M | $0M |
| Total Shareholders' Equity | $47M | $26M | $24M | $15M | $13M | $18M | $16M | $11M | $26M | $12M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ETON viewer.
About TickerBase · Data methodology & sources · Privacy · Terms